CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomography
DOI 10.1055/a-0895-5078
Bibliografische Angaben
Nachweis in CareLit
Autor:innenViktor Fech, Ian Alberts, Axel Rominger, Ali Afshar-Oromieh
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe04/2019
Jahrgang / SeitenJg. 58 · S. 331-332
Kernaussage aus der Literatur
Abstract-Vorschau
AbstractA patient with bone metastases of prostate cancer was referred for 68Ga-PSMA-11 PET/CT. Compared to a 68Ga-PSMA-11 PET/CT four months previously, the CT-component of the current PET/CT showed morphological progress in all lesions despite continuous therapy with docetaxel and denosumab. Contrarily, the PET-component showed a reduction of tracer-uptake, which correlated with PSA decrease between the two PET/CT…
Zitieren
Zitierempfehlung
Viktor Fech, Ian Alberts, Axel Rominger, Ali Afshar-Oromieh (2019) PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomography. Nuklearmedizin - NuclearMedicine, 58 (04), 331-332. https://doi.org/10.1055/a-0895-5078
Mit CareLit weiterarbeiten